Accounting Policies continued Contingenciesand Provisions continued The Group operates in multiple tax jurisdictions around the world and records provisions for taxation liabilities and tax audits when it is considered probable that a tax charge will arise and the amount can be reasonably estimated.
Although Group policy is to submit its tax returns to the relevant tax authorities as promptly as possible, at any time the   and tax audits.
Significant issues may take many years to resolve.
In estimating the probability and amount of any tax charge management takes into account the views of internal and external advisors and updates the amount of the provision whenever necessary.
The ultimate tax liability may differ from the amount provided  law, settlement .
AdjustedEarnings Per Share Adjusted earnings per share is a trend measure which presents the long-term profitability of the Group excluding the impact of specific transactions that management considers as effect the Groups short-term profitability.
Adjusted attributable profit is the numerator used for this measure.
Reconciliation from attributable profit to adjusted attributable profit is included in Note 12 of the Notes to the Group Accounts.
The Group has identified the following items, where material, as those to be excluded when arriving at adjusted attributable profit: acquisition and disposal related items including amortisation and impairment of acquisition intangible assets: significant restructuring events: gains and losses arising from legal disputes anduninsuredlosses: andtaxation thereon.
3 a. BusinessSegmental Analysis For management purposes, the Group is organised into three business segments Orthopaedics, Endoscopy and Advanced Wound Management.
These business segments are the basis on which the Groupreports its primarysegment information.
The Reconstruction and Trauma and Clinical Therapies segments, reported separately in the annual accounts of the Group for the year ended 31 December 2007, are now combined into a single reporting segment named Orthopaedics.
This reflects the unification of the Orthopaedics reporting structure announced during 2008. Business segment analysis comparative figures have consequently been restated .
91 Group Accounts 3 a. BusinessSegmental Analysis continued Trading profit is a trend measure which presents the long-term profitability of the Group excluding the impact of specific transactions that management considers as affect the Groups short-term profitability.
The Group presents this measure to assist investors in their understanding of trends.
The Group has identified the following items, where material, as those to be excluded from operating profit when arriving at trading profit: acquisition and disposal related items including amortisation and impairment of acquisition intangible assets: significant restructuring events: gains and losses arising from legal disputes: and uninsured losses.
The share of results of associates is segmentally allocated to Orthopaedics.
An impairment loss of $16m was recognised within operating profit in 2008 and included within the administrative expenses line 2007 $1m administrative expenses, 2006 nil.
This is segmentally allocated as $2mOrthopaedicsand$14mEndoscopy 2007Orthopaedics$1m.
Capital expenditure in the Group Cash Flow Statement comprises additions of property, plant and equipment and intangible assets.
In 2007, additions are net of $7m of assets capitalised under finance leases and $11m of assets transferred into property, plant, equipment from inventory.
92 3 a. BusinessSegmental Analysis continued 2008 2007 2006 $ million Depreciation, amortisation and impairment Orthopaedics...................................................... 177 157 111 Endoscopy........................................................ 57 40 32 Advanced WoundManagement....................................... 41 31 23 275 228 166 Amounts comprise depreciation of property, plant and equipment, amortisation of other intangible assets,   follows: , plant andequipment............................ 204 181 142 .................................. 18 16 10 ........................................... 2 1 224 198 152 : ................................... 14 .................................. 37 30 14 51 30 14 275 228 166 Other significant non-cash  operating profit Orthopaedics...................................................... 23 113 16 Endoscopy........................................................ Advanced WoundManagement....................................... 6 7 29 120 16 In 2008, the $29m relates to the utilisation of Plus inventory stepped-up on acquisition, acquisition related costs and restructuring and rationalisation expenses.
The $120m in 2007 relates to the utilisation of Plus inventory stepped-up on acquisition, acquisition related costs, restructuring and rationalisation expenses .
In 2007, additions are net of $7m of assets capitalised under finance leases and $11m of assets transferred into property, plant and equipment from inventory.
